Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canker Cure is a consumer healthcare company focused on providing effective treatments for aphthous ulcers, commonly known as canker sores. The company's primary product, marketed as Canker Sore Cure, is a topical solution designed to provide rapid pain relief and accelerate the healing process of oral lesions. By utilizing a proprietary formulation that creates a protective barrier over the ulcer, the treatment prevents irritation from food and drink while delivering active ingredients directly to the affected area. Canker Cure serves the over-the-counter market, offering a non-prescription alternative for individuals suffering from recurrent oral ulcers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canker Cure.